These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27978599)

  • 1. Impact of postprandial hyperglycemia at clinic visits on the incidence of cardiovascular events and all-cause mortality in patients with type 2 diabetes.
    Takao T; Suka M; Yanagisawa H; Iwamoto Y
    J Diabetes Investig; 2017 Jul; 8(4):600-608. PubMed ID: 27978599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of postprandial hyperglycemia at clinic visits on the incidence of retinopathy in patients with type 2 diabetes: An analysis using real-world long-term follow-up data.
    Takao T; Takahashi K; Yoshida Y; Kushiyama A; Onishi Y; Tahara T; Shimmei A; Kikuchi T; Suka M; Yanagisawa H; Iwamoto Y; Kasuga M
    J Diabetes Investig; 2020 Jul; 11(4):930-937. PubMed ID: 31811705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between postprandial hyperglycemia at clinic visits and all-cause and cancer mortality in patients with type 2 diabetes: A long-term historical cohort study in Japan.
    Takao T; Takahashi K; Suka M; Suzuki N; Yanagisawa H
    Diabetes Res Clin Pract; 2019 Feb; 148():152-159. PubMed ID: 30641172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thresholds for postprandial hyperglycemia and hypertriglyceridemia associated with increased mortality risk in type 2 diabetes patients: A real-world longitudinal study.
    Takao T; Suka M; Yanagisawa H; Kasuga M
    J Diabetes Investig; 2021 May; 12(5):886-893. PubMed ID: 32918856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose Study.
    Afsharian S; Akbarpour S; Abdi H; Sheikholeslami F; Moeini AS; Khalili D; Momenan AA; Azizi F; Hadaegh F
    Diabetes Metab Res Rev; 2016 Sep; 32(6):596-606. PubMed ID: 26787367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.
    Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS
    J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure.
    Takao T; Kimura K; Suka M; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    J Diabetes Complications; 2015 Jul; 29(5):699-706. PubMed ID: 25861721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
    Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
    Wei M; Gaskill SP; Haffner SM; Stern MP
    Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Visit-to-Visit Variability of Systolic Blood Pressure With Cardiovascular Disease and Mortality in Primary Care Chinese Patients With Type 2 Diabetes-A Retrospective Population-Based Cohort Study.
    Wan EY; Fung CS; Yu EY; Fong DY; Chen JY; Lam CL
    Diabetes Care; 2017 Feb; 40(2):270-279. PubMed ID: 27899498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
    Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
    BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study.
    Cavalot F; Pagliarino A; Valle M; Di Martino L; Bonomo K; Massucco P; Anfossi G; Trovati M
    Diabetes Care; 2011 Oct; 34(10):2237-43. PubMed ID: 21949221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study.
    Ong G; Davis TM; Davis WA
    Diabetes Care; 2010 Feb; 33(2):317-21. PubMed ID: 19918016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different glucose tolerance status and incident cardiovascular disease and all-cause mortality among elderly Iranians.
    Mirbolouk M; Hajebrahimi MA; Akbarpour S; Tohidi M; Azizi F; Hadaegh F
    Geriatr Gerontol Int; 2016 Dec; 16(12):1263-1271. PubMed ID: 26463623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study.
    Celis-Morales CA; Petermann F; Hui L; Lyall DM; Iliodromiti S; McLaren J; Anderson J; Welsh P; Mackay DF; Pell JP; Sattar N; Gill JMR; Gray SR
    Diabetes Care; 2017 Dec; 40(12):1710-1718. PubMed ID: 28986505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2008 Apr; 31(4):714-9. PubMed ID: 18083789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HbA1c variability and mortality in patients with type 2 diabetes.
    Takao T; Matsuyama Y; Yanagisawa H; Kikuchi M; Kawazu S
    J Diabetes Complications; 2014; 28(4):494-9. PubMed ID: 24703414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
    Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
    Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hip fracture on all-cause mortality in Japanese patients with type 2 diabetes mellitus: The Fukuoka Diabetes Registry.
    Komorita Y; Iwase M; Idewaki Y; Fujii H; Ohkuma T; Ide H; Jodai-Kitamura T; Yoshinari M; Murao-Kimura A; Oku Y; Nakamura U; Kitazono T
    J Diabetes Investig; 2020 Jan; 11(1):62-69. PubMed ID: 31111663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.